AXIL Brands, Inc. (AXIL)

Verve Therapeutics Revenue

AXIL Brands had revenue of $6.92M in the quarter ending February 28, 2025, with 7.00% growth. This brings the company's revenue in the last twelve months to $27.01M, down -3.17% year-over-year. In the fiscal year ending May 31, 2024, AXIL Brands had annual revenue of $27.50M with 16.91% growth.

• Revenue (ttm): $27.01M
• Revenue Growth: -3.17%
• P/S Ratio: 1.97
• Revenue / Employee: $1,929,105
• Employees: 14
• Market Cap: 56.52M

Revenue History

Fiscal Year End	Revenue	Change	Growth
May 31, 2024	27.50M	3.98M	16.91%
May 31, 2023	23.52M	21.18M	906.78%
May 31, 2022	2.34M	702.65K	43.01%
May 31, 2021	1.63M	620.90K	61.31%
May 31, 2020	1.01M	20.04K	2.02%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.